Free and open to the public.
BEADLE AND TATUM LECTURE
Dr. Jennifer Doudna is Professor of Chemistry and of Molecular and Cell Biology in the Department of Chemistry and Chemical Engineering at the University of California, Berkeley. She is also an Investigator of the Howard Hughes Medical Institute. Her scientific career has been devoted to understanding the function of catalytic and other non-protein-coding RNAs. Doudna has been a leading figure in what is often referred to as the "CRISPR Revolution" for her early fundamental work and ongoing leadership in the development of CRISPR-mediated genome editing. In their seminal 2012 paper A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Doudna and Emmanuelle Charpentier were the first to propose that CRISPR/Cas9 could be used for programmable gene editing, an idea that has since been further developed by many research groups for applications ranging from fundamental protein research to treatments for diseases including sickle cell anemia, cystic fibrosis, Huntington's disease, and HIV. Doudna is the recipient of many prestigious awards, including election to the National Academy of Sciences and the Institute of Medicine.